Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 16;3(7):e2727.
doi: 10.1371/journal.pone.0002727.

Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America

Ross J Davidson  1 , Ian Davis, Barbara M Willey, Keyro Rizg, Shelly Bolotin, Vanessa Porter, Jane Polsky, Nick Daneman, Allison McGeer, Paul Yang, Dennis Scolnik, Roy Rowsell, Olga Imas, Michael S Silverman
Affiliations

Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America

Ross J Davidson et al. PLoS One. .

Abstract

Background: Bacterial resistance to antibiotics is thought to develop only in the presence of antibiotic pressure. Here we show evidence to suggest that fluoroquinolone resistance in Escherichia coli has developed in the absence of fluoroquinolone use.

Methods: Over 4 years, outreach clinic attendees in one moderately remote and five very remote villages in rural Guyana were surveyed for the presence of rectal carriage of ciprofloxacin-resistant gram-negative bacilli (GNB). Drinking water was tested for the presence of resistant GNB by culture, and the presence of antibacterial agents and chloroquine by HPLC. The development of ciprofloxacin resistance in E. coli was examined after serial exposure to chloroquine. Patient and laboratory isolates of E. coli resistant to ciprofloxacin were assessed by PCR-sequencing for quinolone-resistance-determining-region (QRDR) mutations.

Results: In the very remote villages, 4.8% of patients carried ciprofloxacin-resistant E. coli with QRDR mutations despite no local availability of quinolones. However, there had been extensive local use of chloroquine, with higher prevalence of resistance seen in the villages shortly after a Plasmodium vivax epidemic (p<0.01). Antibacterial agents were not found in the drinking water, but chloroquine was demonstrated to be present. Chloroquine was found to inhibit the growth of E. coli in vitro. Replica plating demonstrated that 2-step QRDR mutations could be induced in E. coli in response to chloroquine.

Conclusions: In these remote communities, the heavy use of chloroquine to treat malaria likely selected for ciprofloxacin resistance in E. coli. This may be an important public health problem in malarious areas.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. A comparison of the chemical structures of ciprofloxacin (A) and chloroquine (B).
See this image and copyright information in PMC

References

    1. Goosens H, Ferech M, Stichele RF, Elseviers M for the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross national database study. Lancet. 2005;365:579–87. - PubMed
    1. Turnidge J, Christiansen K. Antibiotic use and resistance - Proving the obvious. Lancet. 2005;365:547–8. - PubMed
    1. Nys S, Okeke IN, Kariuki S, Dinant GJ, Driessen C, et al. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother. 2004;54:952–5. - PubMed
    1. Okeke IN, Lamikanra A, Edleman R. Socioeconomic and behavioural factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerging Infectious Diseases. 1999;5:18–27. - PMC - PubMed
    1. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ. 1998;317:647–50. - PMC - PubMed